tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

GMAB Stock Latest News

Genmab Reports Strong Q1 2025 DARZALEX Sales
Company AnnouncementsGenmab Reports Strong Q1 2025 DARZALEX Sales
1d ago
6K
GMAB
Genmab reports Q1 net sales of Darzalex of $3.24B
PremiumThe Fly
Genmab reports Q1 net sales of Darzalex of $3.24B
1d ago
JNJ
GMAB
Genmab Advances Share Buy-back Program with Significant Transactions
PremiumCompany Announcements
Genmab Advances Share Buy-back Program with Significant Transactions
2d ago
6K
GMAB
Genmab A/S Updates Articles of Association to Enhance Capital Flexibility
PremiumCompany Announcements
Genmab A/S Updates Articles of Association to Enhance Capital Flexibility
6d ago
6K
GMAB
Genmab Announces Share Capital Reduction Following AGM Decision
PremiumCompany Announcements
Genmab Announces Share Capital Reduction Following AGM Decision
6d ago
6K
GMAB
Genmab price target lowered to $37 from $50 at H.C. Wainwright
PremiumThe FlyGenmab price target lowered to $37 from $50 at H.C. Wainwright
7d ago
GMAB
Genmab’s Strong Financial Performance and Strategic Positioning Justify Buy Rating Despite Minor Setbacks
Premium
Ratings
Genmab’s Strong Financial Performance and Strategic Positioning Justify Buy Rating Despite Minor Setbacks
7d ago
GMAB
Genmab A/S Advances Share Buy-back Program as of April 2025
Premium
Company Announcements
Genmab A/S Advances Share Buy-back Program as of April 2025
9d ago
6K
GMAB
Genmab Discloses Managerial Share Transactions
PremiumCompany Announcements
Genmab Discloses Managerial Share Transactions
15d ago
6K
GMAB
Genmab downgraded to Underperform from Market Perform at Bernstein
PremiumThe Fly
Genmab downgraded to Underperform from Market Perform at Bernstein
15d ago
GMAB
Genmab A/S Faces Sell Rating Amid Hexabody Setbacks and Darzalex Patent Concerns
PremiumRatings
Genmab A/S Faces Sell Rating Amid Hexabody Setbacks and Darzalex Patent Concerns
15d ago
GMAB
Genmab Initiates Share Buy-Back Program to Optimize Capital Structure
PremiumCompany Announcements
Genmab Initiates Share Buy-Back Program to Optimize Capital Structure
16d ago
6K
GMAB
Genmab announces EC marketing authorization for TIVDAK
PremiumThe FlyGenmab announces EC marketing authorization for TIVDAK
16d ago
GMAB
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
20d ago
ALLR
ALNY
Genmab announces Tivdak approval in Japan
Premium
The Fly
Genmab announces Tivdak approval in Japan
20d ago
GMAB
Genmab to Defend Against AbbVie’s Trade Secret Misappropriation Claims
PremiumCompany Announcements
Genmab to Defend Against AbbVie’s Trade Secret Misappropriation Claims
23d ago
6K
GMAB
Genmab A/S Updates Articles of Association to Enhance Financial Flexibility
PremiumCompany Announcements
Genmab A/S Updates Articles of Association to Enhance Financial Flexibility
27d ago
6K
GMAB
Genmab’s Promising Oncology Prospects and Strategic Growth Catalysts Highlighted in Buy Rating
PremiumRatings
Genmab’s Promising Oncology Prospects and Strategic Growth Catalysts Highlighted in Buy Rating
29d ago
GMAB
Genmab: Rina-S 120 mg/m2 led to ORR of 55.6% in Phase 2 RAINFOL trial
PremiumThe Fly
Genmab: Rina-S 120 mg/m2 led to ORR of 55.6% in Phase 2 RAINFOL trial
1M ago
GMAB
Genmab’s Promising Pipeline and Strategic Focus Justify Buy Rating Despite GEN3014 Setback
PremiumRatingsGenmab’s Promising Pipeline and Strategic Focus Justify Buy Rating Despite GEN3014 Setback
1M ago
GMAB
Genmab A/S Announces Board Constitution and Stock Grants
Premium
Company Announcements
Genmab A/S Announces Board Constitution and Stock Grants
1M ago
6K
GMAB
Genmab A/S Approves 2024 Annual Report and Strategic Proposals at AGM
Premium
Company Announcements
Genmab A/S Approves 2024 Annual Report and Strategic Proposals at AGM
1M ago
6K
GMAB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >